WashingtonProtecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Feb 9Referred to Rules 2 Review.Latest
- Feb 9Minority; without recommendation.Minor
- Feb 9Minority; do not pass.Minor
- Feb 9APP - Majority; 2nd substitute bill be substituted, do pass.Major
- Feb 9Executive action taken in the House Committee on Appropriations at 10:30 AM.
- Feb 6Public hearing in the House Committee on Appropriations at 10:30 AM.
- Jan 28Referred to Appropriations.Minor
- Jan 23Minority; without recommendation.Minor
- Jan 23Minority; do not pass.Minor
- Jan 23HCW - Majority; 1st substitute bill be substituted, do pass.Major
- Jan 23Executive action taken in the House Committee on Health Care & Wellness at 8:00 AM.
- Jan 20Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
- Jan 12First reading, referred to Health Care & Wellness.Minor
- 2025
- Dec 15Prefiled for introduction.Introduced